Samsung Biologics Secures Landmark W1.8 Trillion Manufacturing Agreement with US Partner

  Samsung Biologics, South Korea’s preeminent contract development and manufacturing organisation (CDMO), has entered into a momentous W1.8 tri...

September 10, 2025 | Wednesday | News
Tolerance Bio and ZipCode Bio Forge Strategic Collaboration to Develop Targeted RNA-Based Thymus Therapeutics

Tolerance Bio, a biopharmaceutical company pioneering innovative approaches to extending healthspan by preserving, restoring, and manipulating the functi...

September 09, 2025 | Tuesday | News
Corner Therapeutics Unveils Breakthrough Hyperactivator Technology Showing Potential for a Universal Influenza Vaccine and Cancer Immunotherapy

Corner Therapeutics, an in vivo T cell modulation and immunotherapy company pioneering novel approaches to cancer and infection, published research in mB...

September 09, 2025 | Tuesday | Reports
NurExone Biologic Secures US Patent Allowance for Proprietary Exosome Production Process Strengthening Global Market Position

NurExone Biologic Inc. , a pioneering biopharmaceutical company developing exosome-based regenerative therapies, is pleased to announce that the United S...

September 09, 2025 | Tuesday | News
23andMe Research Institute, TWP, and Lifebit Launch Open-Source Data Platform for Lung Cancer Genetics Study

23andMe Research Institute, Troper Wojcicki Philanthropies (TWP), and Lifebit today announced the official launch of an open-source data platform for the...

September 08, 2025 | Monday | News
Northstrive Biosciences and Yuva Biosciences Complete Phase II of AI-Driven Drug Discovery Program

Northstrive Biosciences and Yuva Biosciences previously announced the AI Development Program, a collaboration leveraging MitoNova™, YuvaBio&rsquo...

September 08, 2025 | Monday | News
Daiichi Sankyo and Merck Report Positive Phase 2 Results for Ifinatamab Deruxtecan in Extensive-Stage Small Cell Lung Cancer

Daiichi Sankyo (TSE: 4568) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive results from the Phase 2...

September 08, 2025 | Monday | News
Certara Launches Pinnacle 21 Enterprise Plus to Streamline Clinical Data Specifications and Accelerate Regulatory Submissions

Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, announced the availability of Pinnacle 21 Enterprise Plus. The solution enables clinical ...

September 05, 2025 | Friday | News
Andelyn Biosciences Partners with Tern Therapeutics to Advance Late-Stage Manufacturing of Gene Therapy for CLN2 Batten Disease

Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered...

September 05, 2025 | Friday | News
Gilead Breaks Ground on $32 Billion U.S. Innovation Commitment with New Technical Development Center in Foster City

Gilead Sciences celebrates the groundbreaking of its new Pharmaceutical Development and Manufacturing (PDM) Technical Development Center (NTDC) at the co...

September 04, 2025 | Thursday | News
Amgen to Invest $600 Million in New Science and Innovation Center at U.S. Headquarters

Research and Development Infrastructure Investment Expected to Create Hundreds of U.S. Jobs   Amgen  announced plans to invest more than ...

September 04, 2025 | Thursday | News
Regenerex Pharma and Holista Colltech Sign Global Supply and Development Agreement for Advanced Wound Care Solutions

Regenerex Pharma, Inc. (OTC: RGPX), a leading innovator in advanced wound closure systems for chronic wounds, today announced that it has entered into a ...

September 04, 2025 | Thursday | News
New Jersey: A Leading Life Sciences Manufacturing Hub

New Jersey at a Glance – Often dubbed the “Medicine Chest of the World,” New Jersey has a rich legacy and a dynamic present as a global h...

September 03, 2025 | Wednesday | Reports
Thermo Fisher Finalises $4B Solventum Filtration Deal Expanding Bioprocessing Portfolio and Adjacent Markets

Highly Complementary Technologies Strengthen Thermo Fisher’s Portfolio in Bioprocessing and Adjacent Markets Thermo Fisher Scientific Inc. , the w...

September 03, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close